Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit.

ABSTRACT:

Objective

To evaluate the impact of antiretroviral therapy (ART) and the prognostic factors for in-intensive care unit (ICU) and 6-month mortality in human immunodeficiency virus (HIV)-infected patients.

Design

A retrospective cohort study was conducted in patients admitted to the ICU from 1996 through 2006. The follow-up period extended for 6 months after ICU admission.

Setting

The ICU of a tertiary-care teaching hospital at the Universidade de São Paulo, Brazil.

Participants

A total of 278 HIV-infected patients admitted to the ICU were selected. We excluded ICU readmissions (37), ICU admissions who stayed less than 24 hours (44), and patients with unavailable medical charts (36).

Outcome measure

In-ICU and 6-month mortality.

Main results

Multiva

SUBMITTER: Croda J 

PROVIDER: S-EPMC4143892 | biostudies-literature | 2009 May

REPOSITORIES: biostudies-literature